IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.
作者:
Wigginton JM [1]
;
Gruys E [2]
;
Geiselhart L ;
Subleski J ;
Komschlies KL ;
Park JW ;
Wiltrout TA ;
Nagashima K ;
Back TC ;
Wiltrout RH
作者单位:
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
[1]
o.cwru.edu
[2]
期刊:
关键词:
Angiogenesis Inhibitors pharmacology;Antigens;CD95;Antineoplastic Agents;抗原;抗肿瘤药;生物应答调节剂;癌;肾细胞;干扰素Ⅱ型;白细胞介素12
发布时间:
2013-11-21
- 翻译满意度评价:
- 提交
- 浏览:2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文